This inventor holds 1 USPTO granted patent. Top assignee: Europaisches Laboratorium Fur Molekularbiologie (Embl). Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: Giovanni Paolella: Innovator in Synthetic Catalytic Oligonucleotide Structures
Introduction
Giovanni Paolella is a notable inventor based in Gaiberg, Germany. He has made significant contributions to the field of molecular biology, particularly through his innovative work on synthetic catalytic oligonucleotide structures. His research has implications for various applications in biotechnology and medicine.
Latest Patents
Giovanni Paolella holds a patent for a synthetic catalytic oligonucleotide structure. This invention includes nucleotides with a general structural formula that encompasses various nucleoside bases, such as adenin-9-yl (A), cytosin-1-yl (C), guanin-9-yl (G), uracil-1-yl (U), and others. His patent represents a significant advancement in the design of oligonucleotides, which are essential for numerous biochemical applications.
Career Highlights
Paolella is affiliated with the European Molecular Biology Laboratory (EMBL), where he has been involved in cutting-edge research. His work at EMBL has allowed him to explore the complexities of molecular structures and their functionalities. He has dedicated his career to advancing the understanding of synthetic biology and its potential applications.
Collaborations
Throughout his career, Giovanni Paolella has collaborated with esteemed colleagues, including Angus Lamond and Brian Sproat. These collaborations have enriched his research and contributed to the advancement of knowledge in the field of molecular biology.
Conclusion
Giovanni Paolella is a distinguished inventor whose work on synthetic catalytic oligonucleotide structures has made a significant impact in molecular biology. His contributions continue to influence research and applications in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
